A Pune based pharmaceutical firm has developed an indigenous cancer drug which will be sold in the Indian market at an affordable price.
Gennova Biopharmaceuticals, which is a vertically integrated arm of the Pune-based Emcure Pharmaceuticals, revealed that the drug, named as PEGEX (Pegfilgrastim), will cost around Rs 17, 900 and is cheaper than other pegfilgrastim brands which average around Rs 27, 000.
AdvertisementThe COO of Emcure Pharmaceuticals, Arun Khanna said that the drug could be used just once per chemotherapy cycle rather than taking a daily dose of filgrastim injections which might sometimes lead to chem¬otherapy dose delays if the patient had failed to take the injection in time.
"Sometimes, due to logistic reasons, the patient cannot take the recommended daily filgrastim injections leading to chem¬otherapy dose delays and thus probably affecting the outcome. PEGEX (Pegfilgrastim) offers the convenience of one injection per chemotherapy cycle with similar safety and efficacy profile as filgrastim", he added.